Chemours Company Q4 Loss Widens

February 19, 2026 — 05:22 pm EST

Written by RTTNews.com for RTTNews

(RTTNews) - The Chemours Company (CC) reported a fourth-quarter net loss of $47 million or $0.31 per share, compared with a net loss of $11 million or $0.08 per share in the corresponding prior-year quarter.

Adjusted net Income was $7 million or $0.05 per share, compared to adjusted net income of $14 million or $0.09 per share in the corresponding prior-year quarter.

Net sales were $1.33 billion, slightly down from $1.36 billion compared to the corresponding prior-year quarter.

Looking forward to the first quarter, the Company anticipates consolidated Net Sales to increase in the range of 3 to 5% sequentially, driven by TSS, with consolidated Adjusted EBITDA expected to range between $120 million and $150 million.

For the full year 2026, the company expects to deliver 2026 net sales growth in the range of 3 to 5% and adjusted EBITDA of $800 million to $900 million.

RTTNews

Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Chemours Company Q4 Loss Widens

Tags

Latest Articles